Free energy component analysis for drug design: A case study of HIV-1 protease-inhibitor binding

Journal of Medicinal Chemistry

Volumn 44, Issue 25, 2001, Pages 4325-4338

  Kalra, P ^a   Reddy, T V ^a   Jayaram, B ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ARTICLE; BINDING AFFINITY; DRUG DESIGN; DRUG PROTEIN BINDING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; THERMODYNAMICS;

ALGORITHMS; DRUG DESIGN; HIV PROTEASE; HIV PROTEASE INHIBITORS; LIGANDS; MODELS, MOLECULAR; MOLECULAR MIMICRY; PEPTIDES; PROTEIN BINDING; THERMODYNAMICS;

EID: 0035818886     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010175z     Document Type: Article

References (65)

1. Computational alchemy
2. Relative differences in the binding free energies of human immunodeficiency virus-1 protease inhibitors: A thermodynamic cycle - Perturbation approach
3. Determination of the relative binding free energies of peptide inhibitors to the HIV-1 protease
4. Peptide mimetics as enzyme inhibitors: Use of free energy perturbation calculations to evaluate isosteric replacement for amide bonds in a potent HIV protease inhibitor
5. Free energy perturbation studies on binding of A74704 and its diester analog to HIV-1 protease
6. Binding of an antiviral agent to a sensitive and a resistant human rhinovirus. Computer simulation studies with sampling of amino acid side chain conformation. II. Calculation of free energy differences by thermodynamic integration
7. Non Boltzmann thermodynamic integration for macromolecular systems: Relative free energy of binding of trypsin to benzamidine and benzylamine
8. Calculation of relative binding free energy difference of DHFR inhibitors by a Finite Difference Thermodynamic Integration (FDTI) approach
9. Free energy calculations: Applications to chemical and biochemical phenomena
10. Free energy via molecular simulations: Applications to chemical and biochemical systems
11. Methods for calculations of free energies and binding constants: Successes and problems
12. Computational methods to predict binding free energy in ligand receptor complexes
13. Free energy analysis of protein-DNA binding: The EcoRI endonuclease-DNA complex
14. Addivity principles in biochemistry
15. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules
16. A modification of the generalized born theory for improved estimates of solvation energies and pK shifts
17. Solvation free energy of biomolecules: Parameters for a modified generalized born model consistent with the AMBER force field
18. Solvation free energies calculated using the GB/SA model: Sensitivity of results on charge sets, protocols and force fields
19. Structure of complex of synthetic HIV-1 protease with a substrate based inhibitor at 2.3 Å resolution
20. Structure at 2.5 Å synthesized human immunodeficiency virus Type-1 protease complexed with a hydroxyethylene based inhibitor
21. Structure based inhibitors of HIV-1 protease
22. Improving HIV therapy
23. 3D Structure of aspartyl protease from Human Immunodeficiency Virus HIV-1
24. Molecular modelling of HIV-1 protease and its substarte binding site
25. Crystallization of the aspartyl protease from the Human Immunodeficiency Virus HIV-1
26. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes
27. HIV-1 protease as a target for the design of antiviral agents for AIDS
28. Crystal structure of a retroviral protease proves relationship to aspartic protease family
29. Inhibition and catalytic mechanism of HIV-1 aspartic protease
30. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site
31. A new method for predicting binding affinity in computer aided drug design
32. Estimation of binding free energies for HIV proteinase inhibitors by molecular dynamics simulations
33. Estimates of relative binding free energies for HIV protease inhibitors using different levels of approximation
34. What determines the van der Waals coefficients β LIE (Linear Interaction Energy) method to estimate binding free energies using molecular dynamics simulations
35. Methodology for protein-ligand binding studies: Application to a model for drug resistance, the HIV/FIV protease system
36. Empirical free energy calculations of ligand protein crystallographic complexes. I. Knowledge based ligand protein interaction potentials applied to the prediction of human immunodeficiency Virus-1 protease binding affinity
37. QSAR and 3D-QSAR in drug design, Part 2: Applications and problems
38. Nonlinear quantitative structure activity relationship for the inhibition of dihydrofolate reductase
39. Quantitative structure activity relationships of 2,4-Diamino-5-(2-X-Benzyl) pyrimidines versus bacterial and aveian dihydrofolate reductase
40. The frontier orbital phase diagrams: Novel QSAR descriptors for benzene derivatives applied to phenylalkylamine hallucinogens
41. Inhibition of monoamine oxidase B by condensed pyridazines and pyrimidines: Effects of lipophilicity and structure activity relationships
42. Computational alanine scanning to probe protein-protein interactions: A novel approach to evaluate binding free energies
43. Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA
44. The Protein Data Bank
45. A well behaved electrostatic potential based method using charge restraints for determining atom centered charges: The RESP model
46. Structure based design of novel conformationally restricted HIV protease inhibitors
47. The interpretation of protein structures: Estimation of static accessibility
48. Free energy analysis of protein-drug complexation: The carboxypeptidase-inhibitor complexes
49. Free energy analysis of protein-drug complexation: The aspartic proteinase-inhibitor complexes
50. On the magnitude of the electrostatic contribution to ligand-DNA interactions
51. The statistical-thermodynamic basis for computation of binding affinities: A critical review
52. Protein-Protein Recognition
53. Elusive Affinities
54. Free energy analysis of the confomational preferences of A and B forms of DNA in solution
55. Calculation of the affinity of the λ repressor-operator complex based on free energy component analysis
56. The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides
57. Modelling DNA in aqueous solution: Theoretical and computer simulation studies on the ion atmosphere of DNA
58. Crystal structure of Trp repressor/operator complex at atomic resolution